Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-11

Clinical Trial Update: Optima: Optimizing Prograf Therapy in Maintenance Allografts II [Phase 4]

View source ↗

Summary

Phase 4 trial update on optimizing Prograf therapy in maintenance kidney transplant recipients; completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prograf (Tacrolimus)

Snippet

Sponsor: East Carolina University | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2013-02-11